NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma

被引:43
|
作者
Liu, Shangwen [1 ]
Ma, Xin [1 ]
Ai, Qing [1 ]
Huang, Qingbo [1 ]
Shi, Taoping [1 ]
Zhu, Mingyang [1 ]
Wang, Baojun [1 ]
Zhang, Xu [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China
关键词
Clear cell renal cell carcinoma; PTEN; PI3K/AKT pathway; NOTCH1; signaling; EXPRESSION; MUTATIONS; CANCER; GENES; PTEN;
D O I
10.1016/j.urolonc.2011.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Although NOTCH1 plays a wide-ranging role in controlling cell fate, differentiation, and development, its pathologic roles in clear cell renal cell carcinoma (CCRCC) are still unclear. In the present study, the expression pattern of NOTCH1 was examined in CCRCC tissues, and the interaction of NOTCH1 with the phosphatase and tensin homologue deleted on chromosome 10 (PTEN)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway was investigated in vitro. Materials and methods: Thirty-six paired CCRCC and adjacent non-neoplastic renal samples were analyzed by Western blotting and quantitative real-time polymerase chain reaction (qRT-PCR). The alteration of NOTCH1, hairy and enhancer of split 1 (HES1), PTEN, AKT (phosphorylated at Ser473) in CCRCC cell line (786-O), and the human normal kidney tubule epithelial cell line (HKC) were analyzed by Western blotting and qRT-PCR, before and after transfection with siRNA against NOTCH1 or the plasmid containing the ORF clone of NOTCH. The effects of NOTCH1 signaling pathway on cells proliferation, apoptosis, invasion, and migration were detected by MTS assay, flow cytometry analyses, and transwell chamber assay, respectively. Results: The NOTCH1 expression levels were significantly increased in CCRCC tissues compared with the adjacent non-neoplastic renal samples, while it had no significant association with the pathologic parameters. NOTCH1 signaling cascade was constitutively active in human CCRCC cell lines. Blocking NOTCH1 signaling resulted in the attenuation of proliferation, invasion, and migration, as well as PTEN up-regulation with decreased AKT phosphorylation. NOTCH1 overexpression had an opposite effect to NOTCH1 knockdown. Conclusions: Our findings indicated that NOTCH1 receptor expression was up-regulated in CCRCC, and that NOTCH1 could regulate PTEN expression and the activity of the PI3K/AKT pathway via HES1 in 786-O and HKC cell lines. These might provide a basis for the designing new therapeutic strategies for CCRCC. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:938 / 948
页数:11
相关论文
共 50 条
  • [1] Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway
    Wang, Tao
    Chen, Zhiyuan
    Chen, Hui
    Yu, Xi
    Wang, Lei
    Liu, Xiuheng
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 288
  • [2] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Huifang Guo
    Peter German
    Shanshan Bai
    Sean Barnes
    Wei Guo
    Xiangjie Qi
    Hongxiang Lou
    Jiyong Liang
    Eric Jonasch
    Gordon B.Mills
    Zhiyong Ding
    Journal of Genetics and Genomics, 2015, 42 (07) : 343 - 353
  • [3] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Guo, Huifang
    German, Peter
    Bai, Shanshan
    Barnes, Sean
    Guo, Wei
    Qi, Xiangjie
    Lou, Hongxiang
    Liang, Jiyong
    Jonasch, Eric
    Mills, Gordon B.
    Ding, Zhiyong
    JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (07) : 343 - 353
  • [4] Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling
    Xu, Le
    Zhu, Yu
    Xu, Jiejie
    Wu, Kerong
    Li, Jinfeng
    Xu, Wenping
    Liu, Haiou
    Wang, Shanshan
    Yin, Hankun
    Chen, Lin
    Wang, Guomin
    Lin, Zongming
    CANCER SCIENCE, 2012, 103 (07) : 1253 - 1258
  • [5] Prognostic significance of PI3K/AKT/mTOR signaling pathway members in clear cell renal cell carcinoma
    Fan, Demin
    Liu, Qiang
    Wu, Fei
    Liu, Na
    Qu, Hongyi
    Yuan, Yijiao
    Li, Yong
    Gao, Huayu
    Ge, Juntao
    Xu, Yue
    Wang, Hao
    Liu, Qingyong
    Zhao, Zuohui
    PEERJ, 2020, 8
  • [6] Dysregulated ANLN reveals immune cell landscape and promotes carcinogenesis by regulating the PI3K/Akt/mTOR pathway in clear cell renal cell carcinoma
    Gao, Mingzhu
    Tuo, Zhouting
    Jiang, Zhiwei
    Chen, Zhendong
    Wang, Jinyou
    HELIYON, 2024, 10 (01)
  • [7] PTEN suppresses renal cell carcinoma proliferation and migration via inhibition of the PI3K/AKT pathway
    Xu Xu
    Yuan-Yue Tang
    Xiaohong Liang
    Wen Luo
    Dong-Mei Jiang
    Jie Chen
    World Journal of Surgical Oncology, 23 (1)
  • [8] PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K/AKT/mTOR signaling pathway
    Qin, Tianzi
    Huang, Minyu
    Wei, Wenjuan
    Zhou, Wei
    Tang, Qianli
    Huang, Qun
    Tang, Ning
    Gai, Shasha
    PEERJ, 2024, 12
  • [9] Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
    Zhao, Zhonghe
    Jiang, Yan
    Liu, Zhongguo
    Li, Qingyan
    Gao, Tiantian
    Zhang, Shengxia
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [10] FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
    Jiang, Kun
    Xu, Li-zhe
    Ning, Jin-zhuo
    Cheng, Fan
    CANCER CELL INTERNATIONAL, 2023, 23 (01)